The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia

Kim

doi:10.3892/ijo_00000288

The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor protein and mRNA in benign, borderline and malignant ovarian neoplasia

International Journal of Oncology ◽

10.3892/ijo_00000288 ◽

2009 ◽

Vol 34 (6) ◽

Cited By ~ 6

Author(s):

Kim

Keyword(s):

Receptor Protein ◽

Type Ii ◽

Müllerian Inhibiting Substance ◽

Ovarian Neoplasia ◽

Mullerian Inhibiting Substance

Download Full-text

EXPRESSION OF MÜLLERIAN INHIBITING SUBSTANCE TYPE II RECEPTOR PROTEIN AND MRNA IN BENIGN, BORDERLINE, AND MALIGNANT OVARIAN TUMOR

Maturitas ◽

10.1016/s0378-5122(09)70384-6 ◽

2009 ◽

Vol 63 ◽

pp. S96

Author(s):

K. Cheon

Keyword(s):

Ovarian Tumor ◽

Receptor Protein ◽

Type Ii ◽

Müllerian Inhibiting Substance ◽

Malignant Ovarian Tumor ◽

Mullerian Inhibiting Substance

Download Full-text

High level prokaryotic expression of anti-Müllerian inhibiting substance type II receptor diabody, a new recombinant antibody for in vivo ovarian cancer imaging

Journal of Immunological Methods ◽

10.1016/j.jim.2012.08.003 ◽

2013 ◽

Vol 387 (1-2) ◽

pp. 11-20 ◽

Cited By ~ 8

Author(s):

Céline Ortega ◽

Amaury Herbet ◽

Sophie Richard ◽

Nathalie Kersual ◽

Narciso Costa ◽

...

Keyword(s):

Ovarian Cancer ◽

Prokaryotic Expression ◽

Cancer Imaging ◽

Recombinant Antibody ◽

Type Ii ◽

Müllerian Inhibiting Substance ◽

High Level ◽

Mullerian Inhibiting Substance

Download Full-text

Synergistic Cooperation between the β-Catenin Signaling Pathway and Steroidogenic Factor 1 in the Activation of the Mullerian Inhibiting Substance Type II Receptor

Journal of Biological Chemistry ◽

10.1074/jbc.m300804200 ◽

2003 ◽

Vol 278 (29) ◽

pp. 26511-26516 ◽

Cited By ~ 36

Author(s):

Anwar Hossain ◽

Grady F. Saunders

Keyword(s):

Signaling Pathway ◽

Type Ii ◽

Steroidogenic Factor 1 ◽

Müllerian Inhibiting Substance ◽

Mullerian Inhibiting Substance

Download Full-text

Abstract 4574: Towards a new targeted therapy for ovarian cancer : Development of an anti-human müllerian inhibiting substance type II receptor humanized antibody

10.1158/1538-7445.am2011-4574 ◽

2011 ◽

Author(s):

Alexandra Jacquet ◽

Nathalie Kersual ◽

Véronique Garambois ◽

Pierre-Emmanuel Colombo ◽

Rui-Bras Goncalvez ◽

...

Keyword(s):

Ovarian Cancer ◽

Targeted Therapy ◽

Cancer Development ◽

Type Ii ◽

Müllerian Inhibiting Substance ◽

Humanized Antibody ◽

Mullerian Inhibiting Substance

Download Full-text

Abstract 2528: 3C23K: an anti-human Müllerian inhibiting substance type II receptor humanized monoclonal antibody for ovarian cancer targeted therapy

10.1158/1538-7445.am2012-2528 ◽

2012 ◽

Author(s):

Alexandra Jacquet ◽

Nathalie Kersual ◽

Véronique Garambois ◽

Alexandre Fontayne ◽

Fanny Pujols ◽

...

Keyword(s):

Ovarian Cancer ◽

Monoclonal Antibody ◽

Targeted Therapy ◽

Type Ii ◽

Müllerian Inhibiting Substance ◽

Humanized Monoclonal Antibody ◽

Cancer Targeted Therapy ◽

Mullerian Inhibiting Substance

Download Full-text

Development of engineered antibodies specific for the Müllerian inhibiting substance type II receptor: a promising candidate for targeted therapy of ovarian cancer

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-06-0115 ◽

2006 ◽

Vol 5 (8) ◽

pp. 2096-2105 ◽

Cited By ~ 19

Author(s):

Qing-an Yuan ◽

Heidi H. Simmons ◽

Matthew K. Robinson ◽

Maria Russeva ◽

Wayne A. Marasco ◽

...

Keyword(s):

Ovarian Cancer ◽

Targeted Therapy ◽

Type Ii ◽

Promising Candidate ◽

Müllerian Inhibiting Substance ◽

Mullerian Inhibiting Substance

Download Full-text

Abstract 4568: Anti-tumor effect of an anti-human müllerian inhibiting substance type II receptor antibody in mouse models for ovarian cancer: towards a new targeted therapy

10.1158/1538-7445.am2011-4568 ◽

2011 ◽

Author(s):

Nathalie A. Kersual ◽

Veronique Garambois ◽

Imed Salhi ◽

Thierry Chardès ◽

Pierre Emmanuel Colombo ◽

...

Keyword(s):

Ovarian Cancer ◽

Targeted Therapy ◽

Mouse Models ◽

Type Ii ◽

Receptor Antibody ◽

Müllerian Inhibiting Substance ◽

Mullerian Inhibiting Substance

Download Full-text

Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer

Journal of Nuclear Medicine ◽

10.2967/jnumed.118.208611 ◽

2018 ◽

Vol 59 (8) ◽

pp. 1234-1242 ◽

Cited By ~ 7

Author(s):

Emmanuel Deshayes ◽

Riad Ladjohounlou ◽

Pierre Le Fur ◽

Alexandre Pichard ◽

Catherine Lozza ◽

...

Keyword(s):

Ovarian Cancer ◽

Receptor Type ◽

Type Ii ◽

Müllerian Inhibiting Substance ◽

Radiolabeled Antibodies ◽

Mullerian Inhibiting Substance

Download Full-text

Transcriptional regulation of the rat Mullerian inhibiting substance type II receptor in rodent Leydig cells

Proceedings of the National Academy of Sciences ◽

10.1073/pnas.96.24.13831 ◽

1999 ◽

Vol 96 (24) ◽

pp. 13831-13838 ◽

Cited By ~ 28

Author(s):

J. Teixeira ◽

D. J. Kehas ◽

R. Antun ◽

P. K. Donahoe

Keyword(s):

Transcriptional Regulation ◽

Leydig Cells ◽

Type Ii ◽

Müllerian Inhibiting Substance ◽

Mullerian Inhibiting Substance

Download Full-text

EXPRESSION OF MÜLLERIAN INHIBITING SUBSTANCE TYPE II RECEPTOR (MISR II) AND ANTIPROLIFERATIVE EFFECTS OF MIS ON HUMAN CERVICAL CANCER

Maturitas ◽

10.1016/s0378-5122(09)70482-7 ◽

2009 ◽

Vol 63 ◽

pp. S120

Author(s):

E.K. Oh ◽

J.Y. Song ◽

D.J. Kwon ◽

Y.O. Lew ◽

E.J. Kim ◽

...

Keyword(s):

Cervical Cancer ◽

Type Ii ◽

Antiproliferative Effects ◽

Müllerian Inhibiting Substance ◽

Human Cervical Cancer ◽

Mullerian Inhibiting Substance

Download Full-text